| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2017/09/13 | 22:40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/09/13 | 22:34 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/09/07 | 21:51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/08/09 | 21:48 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/08/09 | 21:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/07/25 | 06:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/30 | 06:00 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/30 | 05:52 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/13 | 05:21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/06 | 19:04 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/03 | 06:08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/02 | 05:15 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/02 | 05:11 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/31 | 00:51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/27 | 07:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/27 | 07:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/12 | 05:31 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/10 | 19:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/10 | 05:49 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/09 | 00:28 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/04 | 01:53 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/01 | 22:08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/01 | 22:02 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/04/29 | 06:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |